baber/WOPTO huggingface dataset:
Patent AU-2015203402-B2 (AU)
Title: Electrophotographic image forming apparatus, developing apparatus, and coupling member
Inventor: MORIOKA MASANARI
IPC: G03G15/01
Filed: 2015-06-19
Granted: 2016-06-16
Abstract: - 155 A developing device usable with an electrophotographic image forming apparatus, the apparatus including a driving 5 shaft rotatable by a motor and having a rotating force applying portion, and a movable member, the developing device being mountable to the movable member, and the developing device being movable in a direction substantially perpendicular to an axial direction of the driving shaft in 10 response to movement of the movable member in one direction with the developing device mounted to the movable member, the developing device includes i) a developing roller for developing an electrostatic latent image formed on an electrophotographic photosensitive drum, the developing roller 15 being rotatable about an axis; and ii) a coupling member for transmitting a rotating force to the developing roller, the coupling member including, a rotating force receiving portion engageable with the rotating force applying portion to receive a rotating force from the driving shaft, and a rotating force 20 transmitting portion for transmitting the rotating force received through the rotating force receiving portion to the developing roller, the coupling member being capable of taking a rotational force transmitting angular position for transmitting the rotational force for rotating the developing 25 roller to the developing roller, a pre-engagement angular position which is taken before the coupling member is engaged with the rotating force applying portion and in which the coupling member is inclined away from the rotational force transmitting angular position, and a disengaging angular 30 position which is taken for the coupling member to disengage from the driving shaft and in which the coupling member is inclined away from the rotational force transmitting angular 10156073 1 905731D2 - 156 position in a direction opposite to the pre-engagement angular position; wherein in response to a movement of the developing device when the movable member moves in the one direction, the coupling member moves from the pre-engagement angular position 5 to the rotational force transmitting angular position to be opposed to the driving shaft, and wherein when the movable member makes a further movement in the one direction from a position where the coupling member is opposed to the driving shaft, in response to the further movement, the coupling 10 member is disengaged from the driving shaft by moving from the rotational force transmitting angular position to the disengaging angular position. 10156073 1 905731D2
Patent AU-2015210075-B2 (AU)
Title: Method for manufacturing magnesium fluoride sintered compact, method for manufacturing neutron moderator, and neutron moderator
Inventor: FURUYA HIDAKA
IPC: A61N5/10
Filed: 2015-01-20
Granted: 2017-04-20
Abstract: Provided are a method for manufacturing a magnesium fluoride sintered compact in which cracking or chipping is suppressed and relative density is increased, a method for manufacturing a neutron moderator, and a neutron moderator. The method for manufacturing a magnesium fluoride sintered compact includes a powder packing step (S1) for tap packing a magnesium fluoride powder material into a die, and an intermediate-body sintering (pulsed electric current sintering) step (S2) for performing pulsed electric current sintering for sintering the packed magnesium fluoride powder material while applying a pulsed electric current thereto, and obtaining a magnesium fluoride sintered compact (intermediate body).
Patent AU-2015215881-B2 (AU)
Title: Predictive model generator
Inventor: CARROLL DENNIS
IPC: G06Q50/22
Filed: 2015-08-19
Granted: 2017-03-09
Abstract: Methods, systems, and apparatuses, including computer programs encoded on a computer storage medium, can be implemented to perform actions including receiving input data defining a predictive model, the predictive model including multiple features. The actions further include weighting the predictive model iteratively for each feature, using actual data including values for each feature for multiple entities within a population, by iteratively adjusting a current weight for the feature by a momentum until the momentum equals zero, the momentum being iteratively adjusted by a momentum factor based on whether a model score improves, the model score being calculated based on the actual data. The actions further include calculating a value score for the entity using the weighted predictive model. -/1-
Patent AU-2015225767-B2 (AU)
Title: Compositions based on plant extracts for inhibition of the 5-alpha reductase
Inventor: BONINA ANDREA FILIPPO
IPC: A61P17/14
Filed: 2015-03-05
Granted: 2020-07-02
Abstract: The present invention refers to nutraceutical, cosmetic or pharmaceutical compositions based on a combination of vegetal extracts from flowers or fruits of Opuntia ficus and Oryza sativa (Black rice) for inhibition of the 5-alpha reductase. In particular, the preparations according to the invention are useful in prevention or treatment of benign prostatic hypertrophy or hyperplasia, of androgenic alopecia and acne.
Patent AU-2015241096-B2 (AU)
Title: Lithium-intercalated titanium dioxide, lithium titanate particles made therefrom, and related methods
Inventor: FU GUOYI
IPC: C01G23/00
Filed: 2015-03-30
Granted: 2019-02-28
Abstract: The invention provides a method for preparing lithium-containing particles suitable for use in an electrode of a battery, the method including forming a mixture comprising titanium dioxide precursor particles and an aqueous solution of a lithium compound; and heating the mixture at elevated temperature in a sealed pressure vessel in order to form lithium-inserted titanium dioxide particles, wherein at least one particle size characteristic selected from average primary particle size, particle size distribution, average intra-particle pore size, average inter-particle pore size, pore size distribution, and particle shape of the titanium dioxide particles is substantially unchanged by said heating step. The invention further includes a battery including a first electrode, a second electrode, and a separator including an electrolyte between the first and second electrodes, wherein one of the first and second electrodes comprises lithium-inserted titanium dioxide particles or lithium titanate spinel particles made according to the invention.
Patent AU-2015251884-B2 (AU)
Title: Apparatus
Inventor: TSUDA SHINICHIRO
IPC: H04W16/04
Filed: 2015-02-10
Granted: 2017-12-07
Abstract: [Problem] To enable avoidance of concentration of loads on a particular node when a frequency band is shared between a cellular system employing HetNet and another system. [Solution] Provided is an apparatus comprising: an acquisition unit for acquiring band related information that is related to a frequency band, which is one of shared bands, shared between a cellular system and another system, and which can be used by a macro-cell base station of the cellular system, said band related information being provided by a controller used for a plurality of macro-cell base stations of the cellular system; and a control unit for determining a frequency band which is one of the frequency bands that can be used by the macro-cell base station, said frequency band being able to be used by a small-cell base station corresponding to the macro-cell base station.
Patent AU-2015255272-B2 (AU)
Title: Dental attachment assembly cap and method of use
Inventor: ALLEN RICHARD ROBERT
IPC: A61C8/00
Filed: 2015-06-05
Granted: 2016-09-29
Abstract: A dental attachment assembly and method anchors a dental appliance with an implant and has an abutment member attached to the implant, a retention member in releasable snap engagement with the abutment member, and a cap secured in a recess of the dental appliance and in releasable swivel engagement with the retention member to position and secure the dental appliance onto the implant. The cap includes a cavity with a rounded, concave inner surface which engages with the retention member, an interior top surface of the cavity with a concave recess extending radially along an outer periphery of the interior top surface of the cavity to allow for rotation of the retention member within the cap. A central portion of the interior top surface of the cavity surrounded by the concave recess therefore protrudes vertically into the cavity to minimize vertical displacement of the retention member as it rotates.
Patent AU-2015261711-B2 (AU)
Title: Automated system for sample preparation and analysis
Inventor: DEWITTE ROBERT
IPC: G01N30/06
Filed: 2015-11-30
Granted: 2017-11-09
Abstract: AUTOMATED SYSTEM FOR SAMPLE PREPARATION AND ANALYSIS A sample preparation and analysis system. The system (10) includes a sample preparation system (12) and a sample analysis system (14). The sample preparation system (12) prepares samples in accordance with an assay that is selected from a database containing a plurality of unique assays. The sample analysis system (14) includes an analyzer (110) that is dynamically reconfigurable based on the selected assay so as to analyze the prepared sample in accordance with that selected assay. A data communication link (115a) communicates data from the sample preparation system (12) to the sample analysis system (14) to reconfigure the analyzer (110) in accordance with the selected assay.
Patent AU-2015306982-B2 (AU)
Title: Chemical product dispensing independent of drive fluid flow rate
Inventor: KRAUS PAUL R
IPC: A47L13/26
Filed: 2015-08-20
Granted: 2020-01-02
Abstract: A fluid product dispenser is sized to removably receive a product package containing a supply of the fluid product. The product package includes an internally integrated fluid pump, and the dispenser includes a drive unit powered by flow of a fluid. Flow of the fluid powers the drive unit, which in turn drives the pump internal to the product package, resulting in dispensation of the fluid product in a product/fluid ratio that is independent of the fluid flow rate.
Patent AU-2015321740-B2 (AU)
Title: System for calibrating dorsal horn stimulation
Inventor: HERSHEY BRADLEY L
IPC: A61N1/05
Filed: 2015-09-16
Granted: 2018-03-01
Abstract: An example of a system for applying neuromodulation to a patient includes a modulation output circuit and a modulation control circuit. The modulation output circuit may be configured to deliver dorsal horn stimulation. The modulation control circuit may be configured to control the delivery of the dorsal horn stimulation by executing a neuromodulation algorithm using modulation parameters. The modulation control circuit may include a response input and a parameter calibrator. The response input may be configured to receive response information indicative of one or more responses to the stimulation of the dorsal horn. The parameter calibrator may be configured to adjust one or more of the modulation parameters using the response information.
Patent AU-2015324914-B2 (AU)
Title: Alpha-aminoamide derivative compound and pharmaceutical composition containing the same
Inventor: PARK KI DUK
IPC: C07C309/04
Filed: 2015-09-24
Granted: 2018-10-04
Abstract: The present invention relates to an alpha-aminoamide derivative compound and a pharmaceutical composition comprising the same. According to various embodiments of the present invention, provided is a therapeutic agent which can overcome the disadvantages of conventional drugs used as a MAO-B inhibitor and, more specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of conventional drugs by irreversibly acting via a covalent bond with MAO-B to exhibit a therapeutic effect. Particularly, a new compound may be provided having superior stability and efficacy compared to a conventional reversible MAO-B inhibitor.
Patent AU-2015346022-B2 (AU)
Title: Methods and compositions for enhancing skin pigmentation
Inventor: ROIDER ELISABETH MARIA
IPC: C12P19/36
Filed: 2015-11-16
Granted: 2020-01-02
Abstract: Described herein are methods and compositions useful for enhancing pigmentation, such as skin, eye and/or hair pigmentation comprising administering e.g., an NNT inhibitor or an agent that modifies redox status in a melanocyte. The methods and compositions provided herein are based on the discovery that modification of the reduction/oxidative status of a cell (e.g., a melanocyte) by inhibition of nicotinamide nucleotide transhydrogenase (NNT) enhances skin pigmentation. Thus, modulating the cutaneous pigmentation via modification of such a specific redox-system mechanism can be used to prevent melanoma formation and to treat pigmentation disorders.
Patent AU-2015401745-B2 (AU)
Title: A method for manufacturing a sealing ring, and a sealing ring
Inventor: BACK ARNE
IPC: H04R1/10
Filed: 2015-07-06
Granted: 2020-10-08
Abstract: The invention relates to a method for manufacturing a generally circular, oval or rectangular sealing ring (6) for an acoustic device (1; 1´), said sealing ring (6) being configured for being in contact with the skin of a user during use. The method comprises: forming, in an injection molding step (16), a covering (9) being generally U-shaped in cross-section; and attaching (18) the end sections (9a, 9b) of said covering (9) to a support element (13). The invention also relates to a sealing ring (6) of the above-mentioned type.
Patent AU-2016201718-B2 (AU)
Title: Methods and apparatus for performing knee arthroplasty
Inventor: SMITH RICHARD MICHAEL
IPC: A61F2/38
Filed: 2016-03-17
Granted: 2017-11-23
Abstract: Methods and apparatus for performing knee arthroplasty, including, but not limited to, bicruciate retaining knee 0 arthroplasty, are described herein. Methods and apparatus for preparing a distal femur for a femoral implant as well as 5 methods and apparatus for preparing a proximal tibia for a tibial implant are described. These methods and apparatus, in at least some embodiments and uses, facilitate decreasing the complexity of knee arthroplasty procedures such as bicruciate retaining procedures, while maintaining, if not improving on, the safety, accuracy and / or effectiveness of such procedures. 260 264 252 FIG. 109 250 + FIG. 111
Patent AU-2016202401-B2 (AU)
Title: Sole assembly for an article of footwear
Inventor: JESSIMAN ALEXANDER W
IPC: A43B9/00
Filed: 2016-04-15
Granted: 2018-01-18
Abstract: A footwear construction having a strobel-stitched bottomed upper and a sole assembly with a topsole disposed above the strobel board. The topsole is manufactured from a foam having an average modulus at a stress of 535 kilopascals of from about 750 kilopascals to about 950 kilopascals. The foam also has an energy efficiency of at least about 78%, and a dynamic compression set of less than about 10%. The sole assembly may include an inner sole disposed above the topsole. The inner sole may be manufactured from EVA foam. The topsole may have a thickness of at least 1mm, the inner sole may have a thickness of at least 3mm, and the total thickness of the topsole and inner sole may be at least 5mm. The sole assembly may include a midsole, and possibly an outsole, disposed below the strobel board. - 34 - F ig3
Patent AU-2016203656-B2 (AU)
Title: Ezrin-derived peptides and pharmaceutical compositions thereof
Inventor: HOLMS RUPERT
IPC: A61P31/04
Filed: 2016-06-01
Granted: 2020-02-06
Abstract: Ezrin-Derived Peptides and Pharmaceutical Compositions Thereof The present invention relates to the field of medicine, specifically, to the field of chemical and pharmaceutical industry and concerns ezrin-derived peptides, in particular, a peptide comprising an amino acid sequence of general formula (I) X1 EKKRRETVERE X2X 3, wherein each X represents a non-polar amino acid residue. The use of the peptides as immunostimulatory agents, and more 10 specifically, for use in treating and preventing antiviral, antibacterial and antifungal infections, and treatment of diseases of the GI tract, in particular ulcerative disorders of the GI tract. The present invention also relates to pharmaceutical compositions comprising the peptides. Further, the invention relates to methods of treatment of infection and ulcerative diseases of the GI tract comprising administering the peptides to patients in need thereof.
Patent AU-2016203804-B2 (AU)
Title: Displaying location preview
Inventor: MOORE BRADFORD A
IPC: G01C21/36
Filed: 2016-06-08
Granted: 2018-05-10
Abstract: A non-transitory machine readable medium storing a mapping application for displaying a map is described. The mapping application displays selectable search results on a displayed map. The mapping program displays a banner that overlaps the displayed map to show brief information about one of the search results that is at a particular location on the map and to show a selectable item for displaying a window that overlaps the displayed map and displays detailed information about the search result at the particular location on the map.
Patent AU-2016210633-B2 (AU)
Title: Device and method for materials processing using laser radiation
Inventor: MUEHLHOFF DIRK
IPC: A61F9/011
Filed: 2016-08-02
Granted: 2018-09-06
Abstract: Abstract 5 In a device for material processing by means of laser radiation, said device comprising a source of laser radiation (S) emitting pulsed laser radiation (3) for interaction with the material (5); optics (6) focusing the pulsed processing laser radiation (3) to a center of interaction (7) in the material (5); a scanning unit (10) shifting the positions of the center of interaction within the material (5), wherein each processing laser pulse interacts with the material (5) in a zone (8) 10 surrounding the center of interaction (7) assigned to said laser pulse so that material (5) is separated in the zones of interaction (8); and a control unit (17) which controls the scanning unit (10) and the source of laser radiation (S) such that a cut surface (9) is produced in the material (5) by sequential arrangement of zones of interaction (8), it is envisaged that the control unit (17) controls the source of laser radiation (S) and the scanning unit (10) such that adjacent 15 centers of interaction (7) are located at a spatial distance a s 10 pm from each other. (Fig. 6) / 1 678 90111115678922222 0 1 2 3 4 5 ';78 I ' ~ 9v3 1 141511711920 2122 2324 4,0
Patent AU-2016211938-B2 (AU)
Title: Self-adjusting pneumatically sealed trocar
Inventor: MASTRI DOMINICK
IPC: A61B17/34
Filed: 2016-01-20
Granted: 2020-02-13
Abstract: A surgical access device including a housing having a nozzle assembly, a gas supply plenum, a gas return plenum, and a pressure sensing plenum, as well as an elongated tubular body that extends from the housing portion and defines a central lumen communicating with the nozzle assembly and the gas return plenum, a telescopic cannula assembly associated with the tubular body and including a proximal section arranged coaxially within the tubular body and a distal section coaxially supported within the proximal section and mounted for movement relative to the proximal section between retracted and extended positions, and an elastomeric sheath associated with the telescopic cannula assembly and having a distal anchor portion for securing the surgical access device during a laparoscopic surgical procedure.
Patent AU-2016222390-B2 (AU)
Title: A nasal cannula, conduit and securement system
Inventor: HOPKINS CAROLINE GERALDINE
IPC: A61M16/08
Filed: 2016-08-31
Granted: 2018-07-26
Abstract: - 103 This invention relates to medical breathing tubes comprising a tubular body, the body defining a lumen extending between open terminal ends of the body and an internal form enclosed within the lumen and supportive of the tubular body. The internal form may be of a coated encapsulated 5 internal form, the coating securing the internal form to the tubular body. The internal form may also or separately provide for a series of alternative crests and troughs (e.g. corrugations) of the tubular body. Patient interfaces (such as masks or nasal cannula) can be connected to such tubing. A system for securing patient interfaces in an operational position may also be utilised. D Figure to accompany abstract: Figure 2 WO 2012/053910 PCT/NZ2011/000218 105 110 101 105 lo102 207 - -T - - -2- 1
Patent AU-2016276022-B2 (AU)
Title: Methods of treatment of non-histaminic pruritus in mammals
Inventor: ABERG A K GUNNAR
IPC: A61K31/4535
Filed: 2016-05-19
Granted: 2020-11-26
Abstract: Described herein are methods of treating a mammal in need of treatment for non-histaminic pruritus by administering to the mammal in need thereof a therapeutically effective amount of RS-norketotifen, an isomer, or a pharmaceutically acceptable salt thereof, thereby reducing the desire to scratch in the mammal. Non-histaminergic types of pruritus are resistant to treatment with selective histamine H-1-, H-2- and H-4-receptor inhibitors. In certain aspects, the non-histaminergic pruritus is associated with a dermal disorder, a nerve disorder, or a systemic disorder.
Patent AU-2016286274-B2 (AU)
Title: Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
Inventor: MAHR ANDREA
IPC: C07K14/47
Filed: 2016-06-29
Granted: 2021-01-28
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent AU-2016293498-B2 (AU)
Title: Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Inventor: EISENBACH-SCHWARTZ MICHAL
IPC: A61K39/395
Filed: 2016-07-13
Granted: 2022-01-13
Abstract: A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual by release of a restraint imposed on the immune system by one or more immune checkpoints, for use in treating a disease, disorder, condition or injury of the CNS that does not include the autoimmune neuroinflammatory disease, relapsing- remitting multiple sclerosis (RRMS), and said one or more immune checkpoints is selected from the group consisting of ICOS-B7RP1, V-domain Ig suppressor of T cell activation (VISTA), B7- CD28-like molecule, CD40L-CD40, CD28-CD80, CD28-CD86, B7H3, B7H4, B7H7, BTLA- HVEM, CD137-CD137L, OX40L, CD27-CD70, STimulator of INterferon Genes (STING), T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) and A2a R-Adenosine and indoleamine-2,3-dioxygenase (IDO)-L-tryptophan is provided. The pharmaceutical composition is for administration by a dosage regimen comprising at least two courses of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.